The performance of companies tied to the drug's legacy presents a challenging investment scenario . While the initial success generated substantial returns , generic copies have significantly diminished https://tinybookmarks.com/story21596548/the-copyright-and-the-pharmaceutical-sector-a-risky-opportunity